Wellington Management Group LLP Glycomimetics Inc Transaction History

Wellington Management Group LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$2.69 - $4.24 $9.89 Million - $15.6 Million	-3,677,329 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$3.07 - $5.0 $2.71 Million - $4.41 Million	-881,120 Reduced 19.33%	3,677,329 $11.3 Million
Q2 2020 Aug 14, 2020	SELL	$2.06 - $3.76 $563,300 - $1.03 Million	-273,447 Reduced 5.66%	4,558,449 $17.1 Million
Q1 2020 May 14, 2020	BUY	$1.83 - $5.41 $2.06 Million - $6.09 Million	1,125,919 Added 30.38%	4,831,896 $11 Million
Q4 2019 Feb 11, 2020	BUY	$4.03 - $6.5 $14.9 Million - $24.1 Million	3,705,977 New	3,705,977 $19.6 Million

17.8M

Ticker GLYC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,423,900
Market Cap $22M
Description
GlycoMimetics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. It is developing uproleselan, an E-selectin inhibitor, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML),...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.